Another company’s lung fibrosis study has failed
Post# of 150179
(Total Views: 532)
Posted On: 02/10/2025 11:00:32 AM
Another company’s lung fibrosis study has failed, on safety concerns. I can’t access the whole article because it is behind a paywall on Feuerstein’s site, but the headline says all we need to know:
Quote:
Pliant pauses Phase 2b lung fibrosis study after safety board recommendation
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼